Drug misuse and dependency
Services
-
Drugs Test 1 (DT1) form
Form for the testing of specified class A drugs on persons ages 18 or over.
-
NDTMS: community combined review forms
Combined Review Forms (CRF) for community treatment services to use for Core Dataset P (CDS-P), from April 2020 onwards.
-
NDTMS: secure setting outcomes forms
Outcome monitoring forms for use by secure setting from April 2020 for core dataset P.
Guidance and regulation
- Controlled drugs list
- Drug misuse and dependence: UK guidelines on clinical management
- Extra funding for drug and alcohol treatment: 2022 to 2023
- FRANK: free practical drug advice for adults and children
- ASSIST-Lite screening tool: how to use
News and communications
- £3.6 million social prescribing funding for mental health support
- Barriers to research with synthetic cannabinoid receptor agonists
- ACMD vulnerable groups: young people’s drug use
- Response to the ACMD report on the misuse of fentanyl and fentanyl analogues
- New consequences for drug possession
Research and statistics
- Substance misuse treatment for adults: statistics 2021 to 2022
- Synthetic cannabinoid receptor agonists
- People who inject drugs: HIV and viral hepatitis monitoring
- ACMD Naloxone Review
- Drug misuse prevention review
Policy papers and consultations
- Expanding access to naloxone
- Independent review of drugs: call for evidence, part 2
- NDTMS annual reports and methodology: proposed changes
- From harm to hope: A 10-year drugs plan to cut crime and save lives
- ACMD ageing cohort of drug users report: government response
Transparency and freedom of information releases
- Rough sleeping drug and alcohol treatment grant: privacy notice
- Doctor licensing for diamorphine prescribing: privacy notice
- Individual Placement and Support (IPS-AD) trial: privacy notice
- UK government Drug Recovery Champion annual report
- Standard Operating Procedure for using evidence in ACMD reports